Wellbeing at Work Blog Featuring Coriell Life Sciences
Since DNA doesn’t change, a one-time genetic test for medication safety provides insight that can be used to inform optimal prescription choices throughout an employee’s life.
Since DNA doesn’t change, a one-time genetic test for medication safety provides insight that can be used to inform optimal prescription choices throughout an employee’s life.
Answering the call for real-world data on the clinical and economic outcomes of pharmacogenomics (PGx) and comprehensive medication management (CMM), Coriell Life Sciences (CLS) – an international leader in precision medicine – has released new research on the impact of these tools at scale.
Download Insider Insights
Since DNA doesn’t change, a one-time genetic test for medication safety provides insight that can be used to inform optimal prescription choices throughout an employee’s life.
Coriell Life Sciences uses research and genetic science to develop precise medical care specific to each individual with GeneDose LIVE, powered by Amazon Web Services.
Frequently asked questions.
Innovation in healthcare benefits is booming. However, one particular healthcare technology has begun to emerge as a bona fide game-changer for employers, their population health efforts, and their bottom line: pharmacogenomics.
With a steadfast commitment to protecting personal healthcare information, Coriell Life Sciences (CLS) is proud to announce its GeneDose Live™ clinical decision support system (CDSS) has earned Certified status for information security by HITRUST.
CLS brings a new facet of insight about individual patients to clinicians to make better medication choices.
The Corigen Medication Compatibility Report is redefining the future of medication safety worldwide by delivering the power in knowing which medications your DNA is compatible with … and those that aren’t.